{
     "PMID": "14528308",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20031224",
     "LR": "20151119",
     "IS": "1097-6256 (Print) 1097-6256 (Linking)",
     "VI": "6",
     "IP": "11",
     "DP": "2003 Nov",
     "TI": "Beta-catenin is critical for dendritic morphogenesis.",
     "PG": "1169-77",
     "AB": "Regulated growth and arborization of dendritic processes are critical to the formation of functional neuronal networks. Here we identify beta-catenin as a critical mediator of dendritic morphogenesis. We found that increasing the intracellular levels of beta-catenin and other members of the cadherin/catenin complex, namely N-cadherin and alphaN-catenin, enhances dendritic arborization in rat hippocampal neurons, an effect that does not require Wnt/beta-catenin-dependent transcription. Conversely, proteins that sequester beta-catenin decreased dendritic branch tip number and total dendritic branch length. Enhancement of dendritic growth elicited by depolarization requires beta-catenin and increased Wnt release. These results identify Wnt/beta-catenin signaling as an important mediator of dendritic development and suggest that the intracellular level of the cadherin/catenin complex is a limiting factor during critical stages of dendritic morphogenesis.",
     "FAU": [
          "Yu, Xiang",
          "Malenka, Robert C"
     ],
     "AU": [
          "Yu X",
          "Malenka RC"
     ],
     "AD": "Nancy Friend Pritzker Laboratory, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto, California 94304, USA. yuxiang@stanford.edu",
     "LA": [
          "eng"
     ],
     "PT": [
          "Comparative Study",
          "Journal Article",
          "Research Support, Non-U.S. Gov't",
          "Research Support, U.S. Gov't, P.H.S."
     ],
     "DEP": "20031005",
     "PL": "United States",
     "TA": "Nat Neurosci",
     "JT": "Nature neuroscience",
     "JID": "9809671",
     "RN": [
          "0 (Anesthetics, Local)",
          "0 (CTNNB1 protein, human)",
          "0 (Cadherins)",
          "0 (Calcium Channel Blockers)",
          "0 (Ctnnb1 protein, rat)",
          "0 (Culture Media, Conditioned)",
          "0 (Cytoskeletal Proteins)",
          "0 (DNA-Binding Proteins)",
          "0 (Epitopes)",
          "0 (Excitatory Amino Acid Antagonists)",
          "0 (Luminescent Proteins)",
          "0 (Lymphoid Enhancer-Binding Factor 1)",
          "0 (Proto-Oncogene Proteins)",
          "0 (Trans-Activators)",
          "0 (Transcription Factors)",
          "0 (Wnt Proteins)",
          "0 (Zebrafish Proteins)",
          "0 (beta Catenin)",
          "147336-22-9 (Green Fluorescent Proteins)",
          "4368-28-9 (Tetrodotoxin)",
          "451W47IQ8X (Sodium Chloride)",
          "660YQ98I10 (Potassium Chloride)",
          "76726-92-6 (2-Amino-5-phosphonovalerate)",
          "EC 2.7.11.17 (Calcium-Calmodulin-Dependent Protein Kinases)",
          "EC 3.6.5.2 (rho GTP-Binding Proteins)",
          "I9ZF7L6G2L (Nifedipine)"
     ],
     "SB": "IM",
     "MH": [
          "2-Amino-5-phosphonovalerate/pharmacology",
          "Anesthetics, Local/pharmacology",
          "Animals",
          "Animals, Newborn",
          "Cadherins/metabolism",
          "Calcium Channel Blockers/pharmacology",
          "Calcium-Calmodulin-Dependent Protein Kinases/metabolism",
          "Cells, Cultured",
          "Culture Media, Conditioned/pharmacology",
          "Cytoskeletal Proteins/*physiology",
          "DNA-Binding Proteins/metabolism",
          "Dendrites/drug effects/*physiology",
          "Dose-Response Relationship, Drug",
          "Drug Interactions",
          "Embryo, Mammalian",
          "Epitopes/metabolism",
          "Excitatory Amino Acid Antagonists/pharmacology",
          "Gene Expression Regulation, Developmental",
          "Green Fluorescent Proteins",
          "Hippocampus/cytology/metabolism",
          "Humans",
          "Kidney",
          "Luminescent Proteins/metabolism",
          "Lymphoid Enhancer-Binding Factor 1",
          "Morphogenesis/drug effects/*physiology",
          "Mutation",
          "Neurons/*cytology/drug effects",
          "Nifedipine/pharmacology",
          "Potassium Chloride/pharmacology",
          "Probability",
          "Proto-Oncogene Proteins/antagonists & inhibitors/metabolism",
          "Rats",
          "Rats, Sprague-Dawley",
          "Signal Transduction/drug effects/physiology",
          "Sodium Chloride/pharmacology",
          "Tetrodotoxin/pharmacology",
          "Trans-Activators/*physiology",
          "Transcription Factors/metabolism",
          "Transfection",
          "Wnt Proteins",
          "*Zebrafish Proteins",
          "beta Catenin",
          "rho GTP-Binding Proteins/metabolism"
     ],
     "EDAT": "2003/10/07 05:00",
     "MHDA": "2003/12/25 05:00",
     "CRDT": [
          "2003/10/07 05:00"
     ],
     "PHST": [
          "2003/07/08 00:00 [received]",
          "2003/09/09 00:00 [accepted]",
          "2003/10/07 05:00 [pubmed]",
          "2003/12/25 05:00 [medline]",
          "2003/10/07 05:00 [entrez]"
     ],
     "AID": [
          "10.1038/nn1132 [doi]",
          "nn1132 [pii]"
     ],
     "PST": "ppublish",
     "SO": "Nat Neurosci. 2003 Nov;6(11):1169-77. doi: 10.1038/nn1132. Epub 2003 Oct 5.",
     "term": "hippocampus"
}